English
Chinese
Cart
This product is not clubbable with other items in cart. Please remove this or other items to proceed further.
Deleting
No Items In Cart
On this page, you will find the most up-to-date notices regarding current events and their impact on West Operations.
Current Updates
Current Updates
Ukraine Situation
We are closely monitoring the situation in Ukraine and at this time, do not foresee any negative impact on West’s operations. West leverages its global supply chain and sources it’s raw materials from around the world to minimize risk and provide business continuity. We are committed to providing timely and transparent communications to all our stakeholders as we navigate through these evolving challenges and will provide an update if the situation changes.
Please download the customer letter by clicking the button below
Last Updated on December 9, 2022
Related Blogs
May 22, 2020
SARS-CoV-2 Vaccines – Primary Packaging Challenges
Developing a SARS-CoV-2 vaccine presents numerous and unprecedented challenges; prominent among them are greatly accelerated timelines. Ordinarily for a new drug product, there is sufficient time for selection/evaluation of the vial/stopper packaging system – one that guarantees quality and safety from manufacture through delivery. This is not the case for a SARS-CoV-2 vaccine where the primary packaging system must be chosen quickly, creating a higher risk.
September 02, 2020
SARS-CoV-2 Vaccines – Alternative Vial Components
The need to provide vaccines for the SARS-CoV-2 pandemic has presented the pharmaceutical industry with unprecedented challenges. Among them are accelerated timelines for development/approval and unanticipated volumes for manufacture/delivery. Ordinarily for a new drug product, there is ample time for selecting the primary package system and establishing component availability.
April 22, 2020
From Local Survivor to Lifesaver: Marisa Leuzzi shares her incredible journey with COVID-19
Marisa Leuzzi, Senior Specialist, Global Communications, from our Exton Headquarters, is one of the growing number of coronavirus survivors. Her experiences with her illness is not uncommon – but what she did after her recovery to keep her family whole is remarkable.
May 22, 2020
SARS-CoV-2 Vaccines – Primary Packaging Challenges
Developing a SARS-CoV-2 vaccine presents numerous and unprecedented challenges; prominent among them are greatly accelerated timelines. Ordinarily for a new drug product, there is sufficient time for selection/evaluation of the vial/stopper packaging system – one that guarantees quality and safety from manufacture through delivery. This is not the case for a SARS-CoV-2 vaccine where the primary packaging system must be chosen quickly, creating a higher risk.
September 02, 2020
SARS-CoV-2 Vaccines – Alternative Vial Components
The need to provide vaccines for the SARS-CoV-2 pandemic has presented the pharmaceutical industry with unprecedented challenges. Among them are accelerated timelines for development/approval and unanticipated volumes for manufacture/delivery. Ordinarily for a new drug product, there is ample time for selecting the primary package system and establishing component availability.
April 22, 2020
From Local Survivor to Lifesaver: Marisa Leuzzi shares her incredible journey with COVID-19
Marisa Leuzzi, Senior Specialist, Global Communications, from our Exton Headquarters, is one of the growing number of coronavirus survivors. Her experiences with her illness is not uncommon – but what she did after her recovery to keep her family whole is remarkable.
